title: Diet, apoptosis, and carcinogenesis.
abstract: It is known that long-term withdrawal of choline from the diet induces hepatocellular carcinomas in animal models in the absence of known carcinogens. We hypothesize that a choline deficient diet (CD) alters the balance of cell growth and cell death in hepatocytes and thus promotes the survival of clones of cells capable of malignant transformation. When grown in CD medium (5 microM or 0 microM choline) CWSV-1 rat hepatocytes immortalized with SV40 large T-antigen underwent p53-independent apoptosis (terminal dUTP end-labeling of fragmented DNA; laddering of DNA in agarose gel). CWSV-1 cells which were adapted to survive in 5 microM choline acquired resistance to CD-induced apoptosis and were able to form hepatocellular carcinomas in nude mice. These adapted CWSV-1 cells express higher amounts of both the 32 kDa membrane-bound and 6 kDa mature form of TGF alpha compared to cells made acutely CD. Control (70 microM choline) and adapted cells, but not acutely deficient hepatocytes, could be induced to undergo apoptosis by neutralization of secreted TGF alpha. Protein tyrosine phosphorylation is known to protect against apoptosis. We found decreased EGF receptor tyrosine phosphorylation in acutely choline deficient CWSV-1 cells. TGF beta 1 is an important growth-regulator in the liver. CWSV-1 cells express TGF beta 1 receptors and this peptide induced cell detachment and death in control and acutely deficient cells. Hepatocytes adapted to survive in low choline were also resistant to TGF beta 1, although TGF beta 1 receptors and protein could be detected in the cytoplasm of these cells. The non-essential nutrient choline is important in maintaining plasma membrane structure and function, and in intracellular signaling. Our results indicate that acute withdrawal of choline induces p53-independent programmed cell death in hepatocytes, whereas cells adapted to survive in low choline are resistant to this form of apoptosis, as well as to cell death induced by TGF beta 1. Our results also suggest that CD may induce alterations (mutations?) in growth factor signaling pathways which may enhance cell survival and malignant transformation.
authors.affiliation: Department of Nutrition, School of Public Health, University of North Carolina at Chapel Hill 27599, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Albright
authors.forename: R
authors.initials: R
authors.lastname: Liu
authors.forename: M H
authors.initials: MH
authors.lastname: Mar
authors.forename: O H
authors.initials: OH
authors.lastname: Shin
authors.forename: A S
authors.initials: AS
authors.lastname: Vrablic
authors.forename: R I
authors.initials: RI
authors.lastname: Salganik
authors.forename: S H
authors.initials: SH
authors.lastname: Zeisel
mesh_terms: D000818:Animals; D017209:Apoptosis; D002794:Choline / Q000378:metabolism; D002796:Choline Deficiency / Q000378:metabolism*; D004032:Diet; D004815:Epidermal Growth Factor / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000209:etiology*; D015398:Signal Transduction; D016211:Transforming Growth Factor alpha / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis
chemical_list: D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D016159:Tumor Suppressor Protein p53; D004815:Epidermal Growth Factor; D002794:Choline